These findings indicate that lnc-MRPL39-2:1 is essential in NPC tumorigenesis and metastasis and highlighted its potential as a prognostic marker and therapeutic target for NPC. This evidence concerns the gene MRPL39 and nasopharyngeal carcinoma.